Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-14T17:16:50.848Z Has data issue: false hasContentIssue false
  • English
  • Français

[3H] α,β-methylene ATP binding to P2X purinoceptor is unaffected by volatile anaesthetics

Published online by Cambridge University Press:  23 December 2004

E. Masaki ,
K. Yamazaki ,
S. Hori  and
M. Kawamura
E. Masaki
Affiliation:
Jikei University School of Medicine, Department of Pharmacology, Tokyo, Japan Jikei University School of Medicine, Department of Anesthesiology, Tokyo, Japan
K. Yamazaki
Affiliation:
Jikei University School of Medicine, Department of Internal Medicine, Tokyo, Japan
S. Hori
Affiliation:
Jikei University School of Medicine, Department of Pharmacology, Tokyo, Japan
M. Kawamura
Affiliation:
Jikei University School of Medicine, Department of Pharmacology, Tokyo, Japan
Get access

Abstract

Summary

Background and objective: The P2X receptor is responsible for fast excitatory neurotransmission in the central nervous system. This receptor is suggested as one of the targets of volatile anaesthetics. The study was undertaken to examine the site of action of volatile anaesthetics, especially for P2X purinoceptor-mediated neurotransmission.

Methods: The effect of sevoflurane and isoflurane on [3H] α,β-methylene ATP binding was investigated in rat crude synaptic membranes. The crude synaptic membranes were prepared from Sprague-Dawley rat brains by centrifugation and then incubated with volatile anaesthetics or P2 receptor antagonists.

Results: [3H] α,β-methylene ATP binding was unchanged by either sevoflurane or isoflurane at clinically relevant concentrations. Suramin, a P2 antagonist, significantly (P < 0.05) decreased the binding of [3H] α,β-methylene ATP in a dose-dependent manner (68.7 ± 14.7% at 10 μmol, 49.5 ± 6.4% at 50 μmol, 24.3 ± 5.7% at 100 μmol, n = 10, mean ± SD), whereas pyridoxal-phosphate-6-azophenyl-2′,4′-disulphonic acid (PPADS), another P2 antagonist, did not affect the binding.

Conclusions: The suppressive effect of volatile anaesthetics on ATP-mediated excitatory synaptic transmission could be one site of action. However, the blockade of ATP binding to P2X receptors is not a mechanism of action of volatile anaesthetics.

Keywords

ADENINE NUCLEOTIDES, adenosine triphosphateANAESTHETICS GENERAL, anaesthetics inhalation, isoflurane, sevofluraneMEMBRANE TRANSPORT PROTEINS, ion channelsNEUROTRANSMITTERS
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 21 , Issue 3 , March 2004 , pp. 221 - 225
Copyright
2004 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Yang J, Zorumski CF. Effect of isoflurane on N-methyl-D-aspartate gated ion channels in cultured rat hippocampal neurons. Ann NY Acad Sci 1991; 625: 287–289.Google Scholar
Mihic SJ, Ye Q, Wick MJ, Koltchine VV, et al. Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors. Nature 1997; 389: 385–389.Google Scholar
France CP, Winger GD, Woods JH. Analgesic, anesthetic and respiratory effects of competitive N-methyl-D-aspartate antagonist CGS 19755 in rhesus monkeys. Brain Res 1990; 526: 355–358.Google Scholar
Edwards FS, Gibb AJ. ATP – a fast neurotransmitter. FEBS Lett 1993; 325: 86–89.Google Scholar
Inoue K, Koizumi S, Ueno S. Implication of ATP receptors in brain functions. Prog Neurobiol 1996; 50: 483–492.Google Scholar
Burnstock G, Wood JN. Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr Opin Neurobiol 1996; 6: 526–532.Google Scholar
Masaki E, Ebisawa T, Kondo I, Hayashida K, Matsumoto Y, Kawamura M. P2-purinergic antagonists reduce the minimum alveolar concentration of inhaled volatile anesthetics. Brain Res 2000; 864: 130–133.Google Scholar
Masaki E, Kawamura M, Kato F. Reduction by sevoflurane of adenosine 5′-triphosphate-activated inward current of locus coeruleus neurons in pontine slices of rats. Brain Res 2001; 921: 226–232.Google Scholar
Rampil IJ. Anesthetic potency is not altered after hypothermic spinal cord transection in rats. Anesthesiology 1994; 80: 606–610.Google Scholar
Borges M, Antognini JF. Does the brain influence somatic responses to noxious stimuli during isoflurane anesthesia. Anesthesiology 1994; 81: 1511–1515.Google Scholar
Aston-Jones G, Shipley MT, Chouvet G, et al. Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog Brain Res 1991; 88: 47–75.Google Scholar
Roizen MF, White PF, Eger IIEI, Brownstein M. Effects of ablation of serotonin or norepinephrine brain-stem area on halothane and cyclopropane MACs in rats. Anesthesiology 1978; 49: 252–255.Google Scholar
Salter MW, Koninck YD, Henry JL. Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn. Prog Neurobiol 1993; 42: 125–156.Google Scholar
Zukin SR, Young AB, Snyder SH. Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. Proc Natl Acad Sci USA 1974; 71: 4802–4807.Google Scholar
Andoh T, Furuya R, Oka K, et al. Differential effects of thiopental on neuronal nicotinic acetylcholine receptors and P2X purinergic receptors in PC 12 cells. Anesthesiology 1997; 87: 1199–1209.Google Scholar
Hori S, Kawamura M. Characterization of α,β-methylene ATP binding sites in mouse crude synaptic membranes. Brain Res Bull 1997; 43: 59–63.Google Scholar
Rampil IJ, King BS. Volatile anesthetics depress spinal motor neurons. Anesthesiology 1996; 85: 129–134.Google Scholar
Mazze RI, Rice SA, Baden JM. Halothane, isoflurane, and enflurane MAC in pregnant and nonpregnant female and male rats. Anesthesiology 1985; 62: 339–341.Google Scholar
Park WK, Pancrazio JJ, Suh CK, Lynch III C. Myocardial depressant effects of sevoflurane. Anesthesiology 1996; 84: 1166–1176.Google Scholar
Franks NP, Lieb WR. Selective actions of volatile general anaesthetics at molecular and cellular levels. Br J Anaesth 1993; 71: 65–76.Google Scholar
North RA, Surprenant A. Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 2000: 40; 563–580.Google Scholar
Le KT, Babinski K, Séguéla P. Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor. J Neurosci 1998; 18: 7152–7159.Google Scholar
Soto F, Lambrecht G, Nickel P, Stuhmer W, Busch AE. Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors. Neuropharmacology 1999; 38: 141–149.Google Scholar
Gu JG, Bardoni R, Magherini PC, MacDermott AB. Effects of P2 purinoceptor antagonists suramin and pyridoxal-phosphate-6 azophenyl-2′,4′-disulfonic acid on glutamatergic synaptic transmission in rat dorsal horn neurons of the spinal cord. Neurosci Lett 1998; 253: 167–170.Google Scholar
Dale N, Gilday D. Regulation of rhythmic movements by purinergic neurotransmitters in frog embryos. Nature 1996; 383: 259–263.Google Scholar
Martin DC, Abraham JE, Plagenhoef M, Aronstam RS. Volatile anesthetics and NMDA receptors. Enflurane inhibition of glutamate stimulated [3H] MK-801 binding and reversal by glycine. Neurosci Lett 1991; 132; 73–76.Google Scholar
Eckenhoff RG. An inhalational anesthetic binding domain in the nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 1996; 93: 2807–2810.Google Scholar